Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
ConclusionLowering the target LDL-C level from 100 to 70 mg/dL among treatment-naïve CAD patients could be cost-effective given the health benefits of preventing cardiovascular events and deaths.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
More News: Cardiology | Cardiovascular | Chia | Cholesterol | Databases & Libraries | General Medicine | Heart | Statin Therapy | Stroke | Taiwan Health